Skip to main content
Free shipping on orders over $49.00
Support: 1-808-301-6565
Sign In Cart
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER .428 g/40mL, 1.71 g/40mL, 1.77 g/40mL emulsion by SHISEIDO AMERICAS CORPORATION
Over the counter

SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER

TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE

Listed by SHISEIDO AMERICAS CORPORATION

Strength
.428 g/40mL, 1.71 g/40mL, 1.77 g/40mL
Form
Emulsion
Route
Topical

What it contains

  • Titanium Dioxide .428 g/40mL
  • Octinoxate 1.71 g/40mL
  • Ensulizole 1.77 g/40mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Emulsion
Route Topical
Approval route OTC monograph
NDC code 58411-657
FDA application M020
Package sizes listed 1
Marketed since May 2021

Other products containing Titanium Dioxide

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.